Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Most linked-to pages

From GxPlex

Jump to: navigation, search

Showing below up to 50 results in range #1,301 to #1,350.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 510 (k) (5 links)
  2. Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 512 (f) (5 links)
  3. Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Sec 737 (8) (5 links)
  4. Reference:USA FDA Guidance for Industry Investigator Responsibilities โ€” Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 III. B. (5 links)
  5. Reference:USA FDA Information - Observations and citations 20-Mar-2024 - (5 links)
  6. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 2.1.1. (5 links)
  7. Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 5.3.2 (5 links)
  8. Reference:USA NIH - SCORE Manual: Appendix Source Documents Requirements Rev 01 16-Aug-2025 Page 3 - CRF (5 links)
  9. Reference:USA U.S. Code Title 21 30-Sep-2023 ยง 321 (h) (5 links)
  10. Reference:WHO WHO - EXPERT COMMITTEE ON SPECIFICATIONS FOR PHARMACEUTICAL PREPARATIONS Forty-fifth report - (5 links)
  11. Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Platform, basket and umbrella trials (5 links)
  12. Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.1.8 (5 links)
  13. Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.4 (5 links)
  14. Reference:WHO WHO - Guidance for best practices for clinical trials 2024 2.5 (5 links)
  15. Reference:WHO WHO - Guidance for best practices for clinical trials 2024 Annex 2 2.5 (5 links)
  16. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.3 c) (5 links)
  17. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.17 (5 links)
  18. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 8 - Introduction (5 links)
  19. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 9.3 (5 links)
  20. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - Good Clinical Practice (GCP) (5 links)
  21. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - adverse reaction (5 links)
  22. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - case -report form (CRF) (5 links)
  23. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial (5 links)
  24. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - clinical trial Phases (5 links)
  25. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - comparator product (5 links)
  26. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - ethics committee (5 links)
  27. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - investigational product (synonym: study product) (5 links)
  28. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - investigator (5 links)
  29. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - principal investigator (5 links)
  30. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - raw data (5 links)
  31. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - sponsor (5 links)
  32. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - validation (5 links)
  33. Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - verification (validation) of data (5 links)
  34. Reference:WHO WHO - HANDBOOK FOR GOOD CLINICAL RESEARCH PRACTICE (GCP) 2005 Page 94 (5 links)
  35. Reference:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026 - (5 links)
  36. Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Amendment approval (5 links)
  37. Reference:WMA Declaration of Helsinki 2024 Paragraph 25 โ€“ 28 (5 links)
  38. Reference:WMA Declaration of Helsinki 2024 Paragraph 31 โ€“ 32 (5 links)
  39. Reference:WMA Declaration of Helsinki 2024 Paragraph 36 (5 links)
  40. Reference:WMA Declaration of Helsinki 2024 Paragraph 9 (5 links)
  41. Glossary:TAG-00086-Fol-Fol (5 links)
  42. Glossary:TAG-00092-Dru-nte (5 links)
  43. Glossary:TAG-00100-Lab-bor (5 links)
  44. Glossary:TAG-00117-Ins-sfe (5 links)
  45. Glossary:TAG-00128-Dat-rkz (5 links)
  46. Glossary:TAG-00130-Dir-gDi (5 links)
  47. Glossary:TAG-00167-Lab-ttP (5 links)
  48. Glossary:TAG-00183-Aut-Ver (5 links)
  49. Glossary:TAG-00191-Hea-ken (5 links)
  50. Glossary:TAG-00196-Con-odu (5 links)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://gxplex.org/index.php?title=Special:MostLinkedPages"